161 related articles for article (PubMed ID: 3365882)
1. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
Dao MT; Villeneuve JP
Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
[TBL] [Abstract][Full Text] [Related]
2. Triamterene kinetics and dynamics in cirrhosis.
Villeneuve JP; Rocheleau F; Raymond G
Clin Pharmacol Ther; 1984 Jun; 35(6):831-7. PubMed ID: 6734036
[TBL] [Abstract][Full Text] [Related]
3. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
Kabakov AI; Zharov EI
Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
[TBL] [Abstract][Full Text] [Related]
4. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
Radó JP; Sawinsky I; Juhos E
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
[TBL] [Abstract][Full Text] [Related]
5. Influence of triamterene and hydroxytriamterene sulfuric acid ester on diuresis and saluresis in rats after oral and intravenous application.
Leilich G; Knauf H; Mutschler E; Völger KD
Arzneimittelforschung; 1980; 30(6):949-53. PubMed ID: 7191270
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
[TBL] [Abstract][Full Text] [Related]
7. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Radó JP; Marosi J; Takó J
Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
[No Abstract] [Full Text] [Related]
8. [An experimental and clinical pharmacological study of the influence of triamterene on the diuretic and saluretic properties of furosemide xantinol].
Celdrán E; Bekett PR; Roberts DJ
Arzneimittelforschung; 1976; 26(11):2073-6. PubMed ID: 14648
[TBL] [Abstract][Full Text] [Related]
9. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
Thompson EJ; Torres E; Grosberg SJ; Martinez-Maldonado M
Clin Pharmacol Ther; 1977 Apr; 21(4):392-4. PubMed ID: 321176
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis and therapy of ascites in liver cirrhosis].
Dölle W
Internist (Berl); 1966 Jan; 7(1):48-54. PubMed ID: 4861685
[No Abstract] [Full Text] [Related]
11. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
Rector WG
Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
[TBL] [Abstract][Full Text] [Related]
12. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
[TBL] [Abstract][Full Text] [Related]
13. [Saluretic and diuretic effects of xipamide-triamterene combinations in varying dose ratios in rats].
Armah B; Dies R; Heinz N
Arzneimittelforschung; 1983; 33(1):131-5. PubMed ID: 6681965
[TBL] [Abstract][Full Text] [Related]
14. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
Vesin P
Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
[No Abstract] [Full Text] [Related]
16. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
Mansurov KhKh; Dustov AD
Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
[TBL] [Abstract][Full Text] [Related]
17. Propranolol in the treatment of cirrhotic ascites.
Rector WG; Reynolds TB
Arch Intern Med; 1984 Sep; 144(9):1761-3. PubMed ID: 6476994
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
Sanchis Closa A; Lambert C; du Souich P
Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):461-6. PubMed ID: 8225696
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of the kaluretic properties of furosemide by triamterene (Dyrenium) in healthy volunteers.
Levinson B; Shenouda M; Stypinski D
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):92-100. PubMed ID: 15726878
[TBL] [Abstract][Full Text] [Related]
20. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
Boivin P; Fauvert R
Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
